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Abstract Interferon-inducible proteins, p200, have a modular
organization consisting of one (p203) or two (p202 and p204)
200 amino acid motifs, designated as type a or b domains. The
relationship between this domain organization and the anti-
proliferative activity was investigated by generating a hybrid
protein with the 204 a domain upstream from the 203 b domain.
This 204a/203b protein inhibits the proliferation of transfected
cells, delays G0/G1 progression into S phase following serum
restimulation, and inhibits the E2F-mediated transcriptional
activity. These results demonstrate for the first time that both a
and b domains are needed for inhibition of proliferation by the Ifi
200 proteins.
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1. Introduction
Interferons (IFNs) are proteins involved in host resistance
against infections and tumors through their exertion of anti-
microbial, immunomodulatory and cell growth regulatory ac-
tivities [1^3]. Following their binding to speci¢c cell surface
receptors, they induce the expression of a de¢ned set of genes
that elicit a number of cellular responses [4^6]. In vivo and in
vitro studies have demonstrated that IFNs inhibit the growth
of both normal and transformed cells by activating multiple
pathways, namely induction of G0/G1 arrest, lengthening of S
phase, oncogene and cyclin down-regulation, maintenance of
pRb hypophosphorylation and inhibition of E2F activities [7^
15]. However, the precise molecular mechanisms that are
regulated by IFNs and responsible for these e¡ects are still
poorly de¢ned.
The IFN-inducible (I¢) 200 protein family is one of the few
examples of a clear link between inhibition of cell prolifera-
tion and activation of speci¢c IFN-induced proteins [16,17]. It
is encoded by a cluster of structurally related genes located in
the q21^23 region of the murine chromosome 1, that are tran-
scriptionally activated following IFN treatment [18]. Three
human genes (MNDA, IFI16 and AIM2) located on human
chromosome 1 within a linkage group highly conserved be-
tween mouse and human [19^21] share amino acid similarity
with the murine proteins and are regarded as their human
homologues [22]. The common features of all these proteins
are: (1) a modular organization consisting of one or two 200
amino acid long conserved motifs, designated as the type a
and type b domains; (2) nuclear translocation upon IFN
treatment.
The best de¢ned member of this family, p202, is a 52 kDa
phosphoprotein [23]. Its constitutive expression in transfected
AKR-2B and L929 cells inhibits colony formation, whereas in
NIH3T3 cells it delays their exit from G0/G1 phase following
serum starvation [24,25]. Consistent with its growth regula-
tory activity, p202 binds the retinoblastoma tumor suppressor
protein family (pRb) and the transcription factors E2F-1 and
E2F-4 [26^28]. Moreover, upon direct binding, p202 modu-
lates the activity of several transcription factors, namely NF-
UB p50 and p65, AP-1, c-Fos and c-Jun, p53 and MyoD
[24,29,30]. Since all these proteins play some roles in the reg-
ulation of cell growth, this modulation may account for p202
growth inhibitory functions, although a formal functional evi-
dence for this activity has not yet been provided.
p204 is a 72 kDa protein that undergoes phosphorylation
and translocates partly into the nucleus upon IFN treatment.
In cell focus assays, it inhibits the colony formation of normal
cells and arrests their progression from G0/G1 to the S phase
[31,32]. Moreover, high levels of p204 expression impair nor-
mal embryo development, since total body overexpression of
p204 is compatible with development to the four-cell stage,
whereas no viable animals with an intact copy of the trans-
gene are obtained [31]. These results show that p204 overex-
pression inhibits cell growth, but do not explain the molecular
mechanisms responsible for this activity.
We have recently cloned a 3.8 kb cDNA corresponding to
the murine 203 IFN-inducible mRNA, another member of the
I¢ 200 gene family [33]. The 203 cDNA encodes a 48 kDa
nuclear protein structurally similar to p202 and p204, but with
only a type b domain. Comparison of p203 amino acid se-
quence with that of the other members of the family revealed
that p203 is most similar to 204. In p203, the carboxy-termi-
nal type b domain is similar (81% of the residues are identical)
to that of p204, and despite the absence of the seven amino
acid repeats in the NH2-terminal segment of p204, about half
of the 100 residues of the two NH2-terminal sequences are
identical [33]. Like p202 and p204, p203 can be induced by
IFN-K in di¡erent cell lines regardless of their histological
origin, whereas its expression in vivo seems to be more tis-
sue-speci¢c and dependent on the host genotype compared to
p204 [34,35].
To investigate whether the 203 gene, like 202 and 204,
functions as a negative regulator of cell proliferation, p203
was overexpressed in NIH3T3 or murine embryo ¢broblast
cells. Cell focus assays and analysis of the cell cycle progres-
sion demonstrated that it is not endowed with growth inhib-
itory activity. Since p203 has only the type b domain, we have
now investigated the relationships between the domain organ-
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ization of I¢ 200 proteins and their antiproliferative activity
on a hybrid protein generated by inserting the 204 a domain
upstream from the 203 b domain. Here we show that this
204a/203b protein, like p204, inhibits the proliferation of
transfected cells, delays G0/G1 progression into S phase fol-
lowing serum restimulation, and inhibits the activity of E2F,
as measured by the inhibition of transcription of a reporter
gene. By contrast, a p204 deletion mutant, obtained by re-
moving the b domain and de¢ned as pvb204 failed to exert
any of these activities.
Taken as a whole, these results demonstrate for the ¢rst
time that both a and b domains are needed for inhibition of
proliferation by the I¢ 200 proteins.
2. Materials and methods
2.1. Cells and culture conditions
NIH3T3 (murine ¢broblasts) from American Type Culture Collec-
tion (ATCC) and B6MEF cells (embryonic ¢broblast cell line derived
from C57BL/6 mice and immortalized through several passages in
culture) were grown as monolayers in DMEM (Gibco/BRL) supple-
mented with 10% calf serum (Gibco/BRL; NIH3T3) or 10% fetal calf
serum (Gibco/BRL; B6MEF). All media were supplemented with glu-
tamine, penicillin and streptomycin (Gibco/BRL).
Cells were arrested in G0/G1 by allowing them to grow to about
60% of con£uence and then incubating for 50 to 60 h in medium
containing 0.5% serum. They were stimulated to reenter the cycle by
replating at subcon£uent density in DMEM containing 10% serum.
2.2. Interferon
Human recombinant IFN-K A/D, used as substitute for murine
IFN-K, is a hybrid molecule composed of residues 1^62 from human
IFN-K A and residues 64^166 from human IFN-K D. Its antiviral
activity is similar on human, bovine, rat, mouse and feline cells [36].
On murine L929 ¢broblasts, its speci¢c activity is 4U108 IU/mg pro-
tein. The IFN stock was a generous gift from Michael Brunda (Ho¡-
man, LaRoche).
2.3. Plasmids
Plasmid pRcRSV204 (1^632) was constructed by ligation of the
blunt-ended 2060 bp EcoRI-XbaI fragment from pSVK3/204, contain-
ing the full-length 204 cDNA, into the blunt-ended HindIII site of the
expression vector pRcRSV (Invitrogen) [31].
Deletion construct pRcRSVvb204 (1^466) (Fig. 1) was constructed
from pRcRSV204 by removing the b domain (466^632) using the
internal restriction sites NdeI and XbaI. After agarose gel electropho-
resis, the termini of the largest DNA segment were ¢lled using the
Klenow fragment of Escherichia coli DNA polymerase I, and ligated
with T4 DNA ligase.
Plasmid pRcRSV203 (1^408) was constructed by cloning the 203
cDNA [32] into the SpeI site of pRcRSV.
Plasmid pRcRSV 204a/203b (Fig. 1) was constructed by ¢rst ob-
taining the a domain (231^431) from 204 cDNA by PCR ampli¢ca-
tion with speci¢c primers (forward: 5P-GAAATCACAACCCCA-
GAATCAG-3P ; reverse: 5P-GCTTGATGAAACTGTGTTCTCC-3P).
The corresponding 600 bp band was then gel puri¢ed, phosphorylated
and inserted into the StyI site (743 nt) of 203 cDNA. The resulting
2161 bp fragment (corresponding to 203 cDNA plus the a domain of
204 cDNA inserted just upstream from the b domain) was then in-
serted into the HindIII and SpeI restricted pRcRSV. The correctness
of all the constructs was con¢rmed by double stranded DNA sequenc-
ing.
2.4. Preparation of protein extracts from murine cell lines and
immunoblotting
Whole cell extracts from cultured cells were prepared by resuspend-
ing pelleted cells in cold 3% SDS lysis bu¡er (125 mM Tris/Cl pH 6.8,
3% SDS, 10 mM dithiothreitol) with the addition of 1 mM phenyl-
methylsulfonyl £uoride, 1 Wg/ml pepstatin, 4 Wg/ml leupeptin and 4 Wg/
ml aprotinin. After a brief sonication, samples were boiled for 5 min
and insoluble materials were removed by centrifugation at 15 000 rpm.
Supernatants were quanti¢ed for protein concentration with a BioRad
Dc protein assay kit (BioRad Laboratories) and stored at 380‡C in
10% glycerol.
After a 10% SDS-PAGE, the proteins were transferred to a PVDF
membrane (Millipore) by electroblotting in transfer bu¡er (25 mM
Tris/Cl pH 8.3, 150 mM glycine, 20% v/v methanol). Filters were
then blocked in 5% non-fat dry milk in 10 mM Tris/Cl pH 7.5,
100 mM NaCl, 0.1% Tween-20 and immunostained with anti-p203
polyclonal antibody (diluted 2000-fold) [33] or with anti-p204 poly-
clonal antibody (diluted 1000-fold) at RT for 1 h [34]. Goat anti-
rabbit IgG horseradish peroxidase conjugate (Amersham) (diluted
4000-fold) was used to detect the immunocomplex and then visualized
by enhanced chemiluminescence (ECL, Amersham). Anti-actin mouse
monoclonal antibody (Boehringer) was used as internal control.
2.5. Cell focus assay
To assay the e¡ect of 203, 204, 204a/203b and vb204 expres-
sion, NIH3T3 and B6MEF cells were transfected with the expres-
sion vectors (pRcRSV203, pRcRSV204, pRcRSV204a/203b or
pRcRSVvb204) or with the pRcRSV empty vector. All plasmids
were puri¢ed by cesium chloride centrifugation. Brie£y, the day before
transfection cells were plated in growth medium at a density of
2.5U105 cells/60 mm diameter dish. The medium was changed 4 h
before transfection. Cells were transfected by the calcium phosphate
procedure [37] with 10 Wg of expression vector. The DNA calcium
precipitates were added to culture medium and the cells were incu-
bated for 18 h. Thereafter, single-cell suspensions were formed by
trypsinization and 5U103 cells were plated onto 100 mm tissue culture
dishes. The transfected cells were cultured for 2 weeks in medium
supplemented with G418 (500 Wg/ml B6MEF; 750 Wg/ml NIH3T3).
Then, foci were washed twice with phosphate-bu¡ered saline (137 mM
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.4)
and stained with 0.1% crystal violet, 20% ethanol and the number of
foci with a diameter of at least 2 mm were counted.
2.6. Transfections
For transient expression of p203, p204, p204a/203b and pvb204, the
day before transfection NIH3T3 cells (106/100 mm diameter dish)
were plated in growth medium and this was changed 4 h before trans-
fection. Cells were transfected using the calcium phosphate precipita-
tion method [37], with 10 Wg of pRcRSV203, pRcRSV204,
pRcRSV204a/203b, pRcRSVvb204 or with the empty pRcRSV re-
spectively. The DNA calcium precipitates were added and the cells
were incubated for 18 h. Thereafter, transfectants were washed twice
with DMEM and cultured in growing medium. After 48 h whole cell
extracts were prepared as described above.
For £ow cytometric analysis, the day before transfection NIH3T3
Fig. 1. Schematic representation of 204, 203, 204a/203b and vb204
proteins. The empty box represents the NH2-terminal protein seg-
ment; the box designated as a, the type a 200 amino acid segment;
the shaded box, the type b 200 amino acid segment from the 203
gene; the grey box, the type b 200 amino acid segment from the
204 gene.
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cells (106/100 mm diameter dish) were plated in growth medium and
this was changed 4 h before transfection. Cells were transfected using
the calcium phosphate precipitation method with 10 Wg of plasmids
encoding 203, 204, 204a/203b, vb204 or the empty vector and 2 Wg of
pCH110 (a L-galactosidase expression vector driven by the SV40 en-
hancer and promoter). The DNA calcium precipitates were added and
cells incubated for 18 h. Thereafter, transfectants were washed twice
with DMEM and synchronized into G0/G1 by serum starvation. After
48 h, stimulation medium (10% serum) was added and cells harvested
for £ow cytometric analysis at the indicated time point.
For reporter gene experiments, NIH3T3 cells were plated in grow-
ing medium at a density of 2.5U105 cells/60 mm diameter dish and
transfected with 2 Wg of pE2WTX4-CAT (a CAT expression vector
driven by four copies of E2F-speci¢c sequences) [38], and with plas-
mids encoding 203, 204, 204a/203b, vb204 proteins or the empty
pRcRSV plasmid in the amount speci¢ed. The inert pBluescript SK
was used to balance the total amount of DNA to 10 Wg. The cultures
were harvested at 48 h and the extracts were assayed for CAT and
L-galactosidase activity with equal appropriate amounts of proteins
[37]. Thereafter, acetylated products were separated by thin-layer
chromatography, visualized by autoradiography, excised from the
plates and counted in a liquid scintillation counter. CAT activity
was expressed as the percentage of input chloramphenicol converted
to the 1P- and 3P-monoacetylated forms.
Reporter gene activity was also normalized to the amount of plas-
mid DNA introduced into recipient cells by determining either L-gal-
actosidase activity or by DNA dot blot hybridization analysis as de-
scribed by Abken and Reifenrath [39].
2.7. Flow cytometric analysis
Floating cells were collected and attached cells were detached with
phosphate-bu¡ered saline/EDTA 0.1%, pooled with £oating cells,
washed in phosphate-bu¡ered saline and divided in two aliquots.
The ¢rst cell aliquot was assayed for L-galactosidase activity to esti-
mate transfection e⁄ciency. The second was resuspended in 1.5 ml
hypotonic £uorochrome solution (Propidium Iodide 50 Wg/ml in 0.1%
sodium citrate plus 0.1% Triton X-100, Sigma Chemical Co), with the
addition of 0.5 ml RNAse A (1 mg/ml) [40]. The mixed cells were
incubated in the dark at RT for 15 min and kept at 4‡C in the dark
overnight before £ow cytometric analysis. The propidium iodide £uo-
rescence of samples was measured by a FACScan £ow cytometer
(Becton and Dickinson, Mountain View, CA, USA). The £ow rate
was set about 200 cells/s and at least 104 cells of each sample were
analyzed. The percentages of cells within the G1, S and G2/M phases
of cell cycle were determined by analysis with the FACScan computer
program provided by Becton and Dickinson.
3. Results
To determine whether p203 inhibits cell proliferation,
NIH3T3 or B6MEF cells were transfected with a p203 expres-
sion vector or a control vector and assayed for growth sup-
pression response by a transient focus assay. pRcRSV203 did
not signi¢cantly reduce the number of foci compared with
cells transfected with the empty vector (data not shown).
To examine whether duplication of the conserved 200 ami-
no acid domain contributes to the growth inhibitory pheno-
type of I¢ 200 proteins, we generated a hybrid protein, 204a/
203b (Fig. 1), in which the 204 type a domain was inserted just
upstream from the 203 type b domain. As a control, a deletion
mutant (designated vb204, Fig. 1) was prepared from p204 by
deleting almost all of the b domain. To evaluate their expres-
sion, the constructs were transiently transfected into NIH3T3
cells, and the protein extracts were examined with rabbit poly-
clonal monospeci¢c antibodies against the p203 (7^196) [33]
or the p204 amino-terminal fragment (42^205) [34]. As shown
in Fig. 2, the anti-p203 antibodies (upper panel) recognized a
protein with an apparent mol. wt. of 48 kDa corresponding to
p203 in both the extracts from NIH3T3 transfected with
pRcRSV203 vector (lane 3) and cells treated with IFN-K
(1000 U/ml for 18 h) (lane 1). In cells transfected with the
204a/203b-encoding vector, they recognized a protein with a
mol. wt. of about 72 kDa (lane 5), corresponding to the size
predicted from the amino acid sequence (Fig. 1). Moreover,
they did not recognize proteins in extracts from NIH3T3 cells
transfected with the empty vector (lane 2), nor in extracts
from pRcRSV204 (lane 4) or pRcRSVvb204 transfected cells
(lane 6).
When the same blot was probed with anti-p204 antibodies
(Fig. 2, middle panel) an IFN-inducible 72 kDa protein (cor-
responding to p204) was revealed in protein extracts from
NIH3T3 cells stimulated with IFN-K (lane 1). The faster mi-
grating band of about 55 kDa stained in these extracts (lane 1)
corresponds to the IFN-inducible protein D3, another mem-
ber of the I¢ 200 family with a strong similarity to the amino-
terminal region of p204 (about 99% of identity) [34,41]. In
cells transfected with the pRcRSV204-encoding vector (lane
4), higher levels of the corresponding 72 kDa protein were
observed compared with the basal levels in extracts from
NIH3T3 transfected with the empty vector (lane 2),
pRcRSV203 (lane 3) or pRcRSV204a/203b (lane 5). Lastly,
these antibodies recognized a protein of about 55 kDa, in
line with the size predicted from its amino acid sequence, in
extracts from NIH3T3 transfected with pRcRSVvb204 (lane
6).
To evaluate their antiproliferative activity, these constructs
were transfected into NIH3T3 and B6MEF cells and assayed
for growth inhibition by a cell focus assay (Table 1). Trans-
fection of both the empty vector pRcRSV and pRcRSV203
generated a conspicuous number of foci, whereas transfection
of pRcRSV204a/203b or pRcRSV204 dramatically reduced
Fig. 2. Transient expression of 203, 204, 204a/203b and vb204 pro-
teins in NIH3T3 transfected cells. Total cell extracts (50 Wg protein/
lane) from NIH3T3 cells stimulated with IFN-K (1000 IU/ml for
18 h) (lane 1) or transiently transfected with the empty vector
pRcRSV (lane 2) or with the expression vector pRcRSV203 (lane
3), pRcRSV204 (lane 4), pRcRSV204a/203b (lane 5) or
pRcRSVvb204 (lane 6) were fractionated by SDS-PAGE and ana-
lyzed by immunoblotting with the anti-p203 antibodies (K203N,
upper panel) and with the anti-p204 antibodies (K204N, middle pan-
el). The membrane was then incubated with goat anti-rabbit Ig
horseradish peroxidase conjugate as secondary antibody and visual-
ized with an ECL kit (Amersham). Immunodetection of actin mono-
clonal antibody was performed as an internal control. The size
markers were 125 kDa, 78 kDa, 49 kDa and 30 kDa, and the elec-
trophoretic mobilities are indicated on the right.
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their number: about 4-fold reduction in NIH3T3 and more
than 2-fold in B6MEF, respectively. By contrast
pRcRSVvb204 failed to suppress cell growth. These results
demonstrate that the I¢ 200 proteins require both domains
to inhibit cell growth.
Previous studies have suggested that p202 and p204, though
expressed at relatively low levels, a¡ect cell cycle progression
[24,25,31]. To determine whether this is also true for the 204a/
203b hybrid protein, NIH3T3 clones constitutively expressing
204a/203b, 203, 204 or the vb204 proteins were generated. The
presence of transfected cDNAs was determined by PCR am-
pli¢cation using two primers discriminating between ampli¢-
cation of the transgenes and the endogenous 203 and 204
genes. However, Western blot analysis performed on inde-
pendent G418-resistant clones revealed that p203 and
pvb204 were expressed at high levels, whereas p204a/203b
and p204 were poorly expressed suggesting that transfected
cells do not tolerate their high expression levels (data not
shown). To circumvent this obstacle, we used transiently
transfected cells in which p204a/203b and p204 were expressed
at high levels (Fig. 2) to establish whether the impairment in
proliferation was related to accumulation in a particular phase
of the cell cycle. To this purpose NIH3T3 cells were trans-
fected with plasmids encoding 203, 204, 204a/203b, vb204 or
the empty vector, synchronized by serum starvation into G0/
G1, stimulated to proliferate by serum addition and analyzed
by £ow cytometric assay. As shown in Fig. 3 (where the rep-
resentative 18 h time point is reported), NIH3T3 transfected
with RSV and 203 rapidly avanced through the G0/G1 and S
phases, by contrast cells expressing either p204a/203b or p204
progressed more slowly. At 18 h, 79.5% of 204a/203b cells
remained in G0/G1 compared with only 36.9% of the 203 cells.
By 24 h, in contrast to 203 cells that have already begun to
return to G1, a signi¢cative percentage of 204a/203b cells
(about 13%) were in S phase (data not shown). A similar
pattern was observed for the 204 transfected cells, whereas
the behavior of cells transfected with its truncated version
vb204 resembled that of p203. The assay of L-galactosidase
activity revealed equal transfection e⁄ciency values among
the di¡erent constructs. Thus, p204a/203b expression in con-
trast to p203 inhibits proliferation by slowing the progress of
cells through the cycle. These results demonstrate that anti-
proliferative activity is phase-dependent when both domains
are present.
Previous observations have demonstrated that I¢ 200 pro-
teins inhibit cell growth by down-regulating E2F activity
[27,28]. To see whether this is also true of p204a/203b,
NIH3T3 cells were cotransfected with the pE2WTX4-CAT
plasmid, in which the CAT expression is driven by an E2F-
Table 1
Analysis of the e¡ects of p203, p204a/203b, p204 and pvb204 on
cell growth by cell focus assays
Vector No. of clonesa
NIH3T3 B6MEF
pRcRSV 80 þ 7.5 44 þ 5.2
pRcRSV203 92 þ 8.1 37 þ 4.3
pRcRSV204a/203b 24 þ 2.4 22 þ 2.0
pRcRSV204 26 þ 2.4 18 þ 2.3
pRcRSVvb204 83 þ 9.0 52 þ 4.2
aFoci at least 2 mm in diameter. The data represent the means of
four independent experiments for each cell line.
Fig. 3. E¡ect of p204a/203b expression on cell cycle phase distribu-
tion. NIH3T3 cells were transfected with 10 Wg of plasmids encod-
ing p203, p204, p204a/203b, pvb204 or the empty pRcRSV and 2 Wg
of pCH110Lgal as an internal control. At 18 h after transfection,
cells were synchronized by serum starvation into G0/G1 for 48 h,
then stimulated with 10% serum and harvested at 18 h later. There-
after, cells were divided in two aliquots: the ¢rst cell was assayed
for L-galactosidase activity as a control for transfection e⁄ciency.
The second cell aliquot was examined for DNA content by propidi-
um iodide staining and £ow cytometry and each graph represents
the analysis of 104 events.
C
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responsive motif repeated four times, and with 203, 204, 204a/
203b or vb204 vectors. As reported in Fig. 4, transfection of
p204 expression construct inhibited CAT activity in a concen-
tration-dependent manner, whereas that of pvb204 abolished
the suppression of E2F-mediated transcription. Transfection
of the 204a/203b plasmid, like p204 also inhibited CAT activ-
ity, whereas p203 was ine¡ective. Inhibition by p204a/203b
and p204 was speci¢c, since the empty pRcRSV did not a¡ect
CAT activity.
These results further demonstrated that duplication of the
conserved 200 amino acid domain, as occurring in the hybrid
204a/203b protein, confers a growth inhibition phenotype sim-
ilar to that observed with the wild-type 202 and 204 proteins.
4. Discussion
The structural hallmark of the I¢ 200 protein family is a
200 amino acid motif, present singly or as a tandem repeat
designated the type a and type b domains respectively. This
study demonstrates that the antiproliferative activity of these
proteins is closely dependent on the simultaneous presence of
both domains because: (i) p203, which contains only one do-
main fails to exert antiproliferative activity; (ii) introduction
of a second domain into p203 to create 204a/203b hybrid
protein, restores it so that it is indistinguishable from that
of p204; (iii) deletion of one of the p204 domains, as in
pvb204, abolishes its antiproliferative activity.
The failure of p203 to inhibit growth is thus a consequence
of its di¡erent molecular structure compared to those of p202
and p204, the only I¢ 200 proteins of this family with a docu-
mented antiproliferative activity [24,25,31]. Their structure is
remarkably similar, and the sequence similarity between the a
domain of p202 and that of p204 is 56%, whereas that of the b
domain is 50%. By contrast, the homologies between the a
and the b domain are 31% and 34% in p202 and p204 respec-
tively. Homology in a given protein is consistent with repeated
duplication during evolution of the 200 gene cluster. In this
model, an ancestral gene encoding only one amino acid motif
has duplicated to give rise to a double length transcription
unit, whose two segments of this double unit then diverged
before undergoing further duplication [42].
The antiproliferative activity of p202 has been related to its
ability to down-regulate E2F-dependent transcriptional activ-
ity by directly binding and inhibiting both E2F-1 and E2F-4
[27,28]. Since members of the E2F family regulate genes
whose products are essential for progression through the cell
cycle (e.g. DHFR, PCNA, cdc2, b-myb and c-myc), it is con-
ceivable that p202 inhibits cell proliferation, at least in part,
by inhibiting E2F activity. It has, in fact, been demonstrated
that the transcription rates of the DHFR, PCNA and b-myb
genes were reduced by about 60^80% in p202 overexpressing
cell lines [27]. The present results show that introduction of an
additional 200 amino acid segment in the backbone of a copy-
bearing protein, namely p203, confers to the hybrid protein
antiproliferative properties indistinguishable from those of the
p204. Consistent is the observation that overexpression of
MNDA, a human I¢ 200 homologue bearing only one copy
of the 200 amino acid motif, does not inhibit cell growth in
colony formation assays (R.C. Briggs, personal communica-
tion). It may be relevant to note that despite the occurrence in
MNDA of a type a domain, the whole protein displays a
remarkably similarity with the amino acid sequence of p203
(40.5% of the residues are identical).
The lack of an apparent antiproliferative activity on behalf
of the natural p203 raises the question of its functions. Con-
servation of two one-copy-bearing I¢ 200 proteins, namely
p203 and pD3 [33,41], indicates that these two genes exert
functions related to the regulation of gene expression, since
the ability of a single 200 amino acid segment to bind several
transcription factors has been well established. Furthermore,
the divergence in the amino-terminal segment of p203 and
pD3 may re£ect individual functions correlated with their
cell- and tissue-speci¢c expression patterns. The IFN-induci-
ble expression of pD3 in macrophages may be involved in
regulation of their di¡erentiation [41].
We have recently observed that p203, pD3 and p204 are
constitutively expressed in various degrees in myeloid and
lymphoid organs [34,35], suggesting that their physiological
levels may be high and not provoke an antiproliferative re-
sponse. Inhibition of endogenous p202 expression unexpect-
edly did not increase cell proliferation. Instead, an increase in
cell susceptibility to apoptosis in response to serum starvation
was observed, consistent with the notion that basal levels of
p202 may be needed for the correct regulation of cell prolif-
eration [43]. These ¢ndings and the data concerning the anti-
proliferative function of I¢ 200 proteins suggest a model in
which their constitutive expression contributes to the physio-
logical regulation of cell proliferation, whereas, on IFN-medi-
ated overexpression, they inhibit cell division and thereby lim-
it tissue proliferation.
In conclusion, the present results indicate that duplication
of the partially conserved 200 amino acid long region of the
I¢ 200 proteins may determine the growth inhibition pheno-
type and thereby contribute to illustrate the molecular mech-
anisms exploited by IFNs to regulate progression throughout
cell cycle.
Fig. 4. Inhibition of E2F-dependent transcription by 204 or 204a/
203b proteins. NIH3T3 cells were transiently transfected with 2 Wg
of the pE2WTX4-CAT indicator plasmid, 2 Wg of pCH110Lgal as
an internal control, and, as indicated, with 4 or 6 Wg of plasmids
encoding p203, p204, p204a/203b, pvb204 or the empty pRcRSV.
The inert pBluescript SK was used to balance the total amount of
DNA to 10 Wg. At 48 h after transfection, cell extracts were pre-
pared and 15 Wg of proteins were assayed for CAT and L-galactosi-
dase activities as described in Section 2. CAT activity was normal-
ized to L-galactosidase activity. The results shown are repre-
sentatives of two independent experiments. The error bars represent
the standard deviations.
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